XYL

SEC source: 0001524472-25-000050 · form4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · EVP, CPSO

10b5-1 filing: No plan indicated

Ownership: Indirect · by Claudia S. Toussaint Revocable Trust

Disclosed balance after: 31,250

F1 · shares: Reflects the sale of shares of common stock from the Claudia S. Toussaint Revocable Trust of which the reporting person is trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 10,421 Shares were executed at a range of prices from $152.51 to $152.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0002040538-25-000002 · primarydocument.xml · nonDerivative · entry 1

Emmerich Meredith · CIK 0002040538 · EVP & Pres, AW

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,992

F1 · shares: Reflects the withholding of 841 shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on October 21, 2024 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

SEC source: 0001694002-25-000003 · primarydocument.xml · nonDerivative · entry 1

Grogan William K · CIK 0001694002 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,199

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on September 18, 2023 (4,254) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-006119 · primarydocument.xml · nonDerivative · entry 1

McShane Geri-Michelle · CIK 0001769064 · VP, CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,957

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,000 Shares were executed at a range of prices from $139.96 to $139.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-25-006071 · primarydocument.xml · derivative · entry 2

Cozad Stacy · CIK 0001663264 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,579

Underlying: Common Stock · 2,579 shares

Expires 2035-09-02

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-006071 · primarydocument.xml · nonDerivative · entry 1

Cozad Stacy · CIK 0001663264 · SVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 735

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-005917 · primarydocument.xml · nonDerivative · entry 1

Glatch Lisa · CIK 0001339795 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,163

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,900 Shares were executed at a range of prices from $140.43 to $140.86. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-25-005649 · primarydocument.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,575

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,800 Shares were executed at a range of prices from $143.63 to $143.65. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-25-004206 · primarydocument.xml · nonDerivative · entry 1

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,304

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 24, 2023, under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-003812 · primarydocument.xml · nonDerivative · entry 1

Tretikov Lila · CIK 0001620654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,680

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-003811 · primarydocument.xml · nonDerivative · entry 1

Peribere Jerome A · CIK 0001484527 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,036

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-003815 · primarydocument.xml · nonDerivative · entry 1

Yadav Uday · CIK 0001479938 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,626

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders.

SEC source: 0001562180-25-003814 · primarydocument.xml · nonDerivative · entry 1

Morelli Mark D · CIK 0001411290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,298

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-003809 · primarydocument.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,375

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders.

SEC source: 0001562180-25-003810 · primarydocument.xml · nonDerivative · entry 1

FRIEL ROBERT F · CIK 0001224110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,031

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-003808 · primarydocument.xml · nonDerivative · entry 1

Glatch Lisa · CIK 0001339795 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,064

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-003807 · primarydocument.xml · nonDerivative · entry 1

ELLIS EARL RAY · CIK 0001835584 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,309

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2026 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-002290 · primarydocument.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,192

F1 · shares: Reflects the transfer of shares of common stock from the reporting person's personal account to the Matthew F. Pine and Angeles Lopez Guerrero Living Trust of which the reporting person is a co-trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.

SEC source: 0001562180-25-002256 · primarydocument.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP, CPSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,939

F1 · shares: Reflects the transfer of shares of common stock from the reporting person's personal account to the Claudia S. Toussaint Revocable Trust of which the reporting person is trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust.

SEC source: 0001562180-25-002198 · primarydocument.xml · derivative · entry 3

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,119 shares

Expires 2030-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The February 27, 2020 option grant vested 1,030 options on February 27, 2021, 1,029 options on February 27, 2022, and 1,060 options on February 27, 2023.

SEC source: 0001562180-25-002198 · primarydocument.xml · nonDerivative · entry 2

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,950

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,119 Shares were executed at a range of prices from $127.50 to $128.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-25-002198 · primarydocument.xml · nonDerivative · entry 1

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,069

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-25-002144 · primarydocument.xml · derivative · entry 2

Emmerich Meredith · CIK 0002040538 · SVP & Pres, AW

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,721

Underlying: Common Stock · 3,721 shares

Expires 2035-03-05

F3 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002144 · primarydocument.xml · nonDerivative · entry 1

Emmerich Meredith · CIK 0002040538 · SVP & Pres, AW

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,833

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

F2 · balance_after: Includes additional shares due to dividend reinvestment.

SEC source: 0001562180-25-002145 · primarydocument.xml · derivative · entry 2

Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,392

Underlying: Common Stock · 49,392 shares

Expires 2035-03-05

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002145 · primarydocument.xml · nonDerivative · entry 1

Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,199

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002150 · primarydocument.xml · derivative · entry 2

Grogan William K · CIK 0001694002 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,223

Underlying: Common Stock · 15,223 shares

Expires 2035-03-05

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002150 · primarydocument.xml · nonDerivative · entry 1

Grogan William K · CIK 0001694002 · SVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,415

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002149 · primarydocument.xml · derivative · entry 3

Toussaint Claudia S · CIK 0001421560 · SVP, CPSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,104

Underlying: Common Stock · 7,104 shares

Expires 2035-03-05

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002149 · primarydocument.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP, CPSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,136

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002152 · primarydocument.xml · derivative · entry 2

Yarkadas Hayati · CIK 0001657363 · SVP & President, WI

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,119

Underlying: Common Stock · 8,119 shares

Expires 2035-03-05

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002152 · primarydocument.xml · nonDerivative · entry 1

Yarkadas Hayati · CIK 0001657363 · SVP & President, WI

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,616

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002151 · primarydocument.xml · derivative · entry 2

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,751

Underlying: Common Stock · 5,751 shares

Expires 2035-03-05

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002151 · primarydocument.xml · nonDerivative · entry 1

Aulick Rodney · CIK 0001720147 · SVP & President, WSS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,774

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002148 · primarydocument.xml · derivative · entry 2

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,861

Underlying: Common Stock · 1,861 shares

Expires 2035-03-05

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002148 · primarydocument.xml · nonDerivative · entry 1

McShane Geri-Michelle · CIK 0001769064 · VP, Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,950

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002146 · primarydocument.xml · derivative · entry 2

McGann Michael J. · CIK 0001962070 · SVP & President, MCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,751

Underlying: Common Stock · 5,751 shares

Expires 2035-03-05

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002146 · primarydocument.xml · nonDerivative · entry 1

McGann Michael J. · CIK 0001962070 · SVP & President, MCS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,180

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002147 · primarydocument.xml · derivative · entry 2

Cho Albert · CIK 0002025025 · SVP, Strategy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,721

Underlying: Common Stock · 3,721 shares

Expires 2035-03-05

F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002147 · primarydocument.xml · nonDerivative · entry 1

Cho Albert · CIK 0002025025 · SVP, Strategy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,970

F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002143 · primarydocument.xml · derivative · entry 7

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,905

Underlying: Common Stock · 4,905 shares

Expires 2035-03-05

F5 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002143 · primarydocument.xml · nonDerivative · entry 4

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,413

F2 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.

SEC source: 0001562180-25-002143 · primarydocument.xml · derivative · entry 6

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,868 shares

Expires 2032-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The March 1, 2022 option grant vested 2,623 options on March 1, 2023, 2,623 options on March 1, 2024, and 2,622 options on March 1, 2025.

SEC source: 0001562180-25-002143 · primarydocument.xml · derivative · entry 5

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,079

Underlying: Common Stock · 4,158 shares

Expires 2033-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The March 1, 2023 option grant vested 2,079 options on March 1, 2024, 2,079 options on March 1, 2025, and will vest 2,079 options on March 1, 2026.

SEC source: 0001562180-25-002143 · primarydocument.xml · nonDerivative · entry 3

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,015

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 12,026 Shares were executed at a range of prices from $125.25 to $125.35. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001562180-25-002143 · primarydocument.xml · nonDerivative · entry 2

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,041

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-25-002143 · primarydocument.xml · nonDerivative · entry 1

Capers Dorothy Trefon · CIK 0001905353 · SVP & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,883

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001562180-25-001951 · primarydocument.xml · nonDerivative · entry 5

Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,125

F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2022 (454), March 1, 2023 (649), and March 1, 2024 (1,031) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

SEC source: 0001562180-25-001951 · primarydocument.xml · nonDerivative · entry 4

Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,259

F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2022 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).

SEC source: 0001562180-25-001951 · primarydocument.xml · nonDerivative · entry 3

Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,343

F4 · shares: Reflects the acquisition of 3,026 shares of common stock upon vesting of performance-based stock units granted on March 1, 2022 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.